Adamas Pharmaceuticals, Inc. (ADMS): Price and Financial Metrics


Adamas Pharmaceuticals, Inc. (ADMS)

Today's Latest Price: $5.60 USD

0.01 (-0.18%)

Updated Feb 18 8:00pm

Add ADMS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ADMS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ADMS is 2.61 -- better than 78.64% of US stocks.
  • ADMS's price/sales ratio is 28.19; that's higher than the P/S ratio of 95.53% of US stocks.
  • Revenue growth over the past 12 months for Adamas Pharmaceuticals Inc comes in at 142.28%, a number that bests 95.81% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to ADMS, based on their financial statements, market capitalization, and price volatility, are DERM, QTRX, NEPT, IGC, and ECOR.
  • Visit ADMS's SEC page to see the company's official filings. To visit the company's web site, go to www.adamaspharma.com.
ADMS Daily Price Range
ADMS 52-Week Price Range

ADMS Stock Price Chart More Charts


ADMS Price/Volume Stats

Current price $5.60 52-week high $12.57
Prev. close $5.61 52-week low $3.35
Day low $5.58 Volume 288,100
Day high $5.80 Avg. volume 488,009
50-day MA $5.25 Dividend yield N/A
200-day MA $5.42 Market Cap 156.00M

Adamas Pharmaceuticals, Inc. (ADMS) Company Bio


Adamas Pharmaceuticals is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company was founded in 2000 and is based in Emeryville, California.


ADMS Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ADMS Latest Social Stream


Loading social stream, please wait...

View Full ADMS Social Stream

ADMS Price Returns

1-mo N/A
3-mo 2.38%
6-mo -7.59%
1-year -47.57%
3-year -67.59%
5-year -67.59%
YTD 47.76%
2019 -55.62%
2018 -74.80%
2017 100.53%
2016 -40.32%
2015 63.04%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7217 seconds.